Categories AlphaGraphs, Earnings, Health Care

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings.

AbbVie Q1 2025 earnings infographic

The company reported worldwide net revenues of $13.3 billion for the March quarter, up 8% from the corresponding period of 2024. The main operating segments registered growth.

Net income, adjusted for special items, rose to $2.46 per share in Q1 from $2.31 per share in the year-ago quarter, exceeding estimates. On a reported basis, net income was $1.29 billion or $0.72 per share in the first quarter, compared to $1.37 billion or $0.77 per share last year.

Prior Performance

  • AbbVie Q4 2024 earnings infographic
  • AbbVie Q2 2024 earnings infographic
  • AbbVie Q1 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Take-Two Interactive Software (TTWO) Earnings: 4Q25 Key Numbers

Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported its earnings results for the fourth quarter of 2025. Net revenue increased 13% year-over-year to $1.58 billion. Net loss was $3.73 billion, or

Autodesk looks set to report higher Q1 2026 revenue and profit

Autodesk Inc. (NASDAQ: ADSK), a market leader in design software, delivered better-than-expected quarterly results in fiscal 2025, leveraging the digitization trend in the engineering and construction industries. After successfully transitioning

Applied Materials Q2 earnings rise on higher revenues, beat estimates

Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) reported higher adjusted earnings for the second quarter of 2025, driven by an increase in revenues. Earnings also exceeded analysts' estimates. Adjusted

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top